Cargando…
The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer
Colorectal cancer (CRC) is one of the most frequent malignant neoplasms worldwide, and the effect of treatments is limited. Fibroblast growth factor 1 (FGF1) has been involved in a wide variety of several malignant diseases and takes part in the tumorigenesis of CRC. However, the function and mechan...
Autores principales: | Duan, Tinghui, Zhou, Diyuan, Yao, Yizhou, Shao, Xinyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450504/ https://www.ncbi.nlm.nih.gov/pubmed/34552869 http://dx.doi.org/10.3389/fonc.2021.706838 |
Ejemplares similares
-
Corrigendum: The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer
por: Duan, Tinghui, et al.
Publicado: (2021) -
STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway
por: Yao, Huihui, et al.
Publicado: (2022) -
Targeting PI3K/mTOR Signaling in Cancer
por: Arcaro, Alexandre
Publicado: (2014) -
Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014) -
HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway
por: Wang, Haowei, et al.
Publicado: (2022)